Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.435 USD | +2.14% | -2.38% | -2.38% |
Mar. 13 | Transcript : Spero Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 | |
Mar. 13 | Spero Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.38% | 77.34M | |
-0.49% | 105B | |
+3.31% | 97.5B | |
+3.14% | 22.19B | |
-16.16% | 21.33B | |
-7.19% | 18.68B | |
-41.41% | 16.6B | |
-22.87% | 14.52B | |
+6.32% | 14.09B | |
+21.46% | 10.99B |
- Stock Market
- Equities
- SPRO Stock
- News Spero Therapeutics, Inc.
- Earnings Flash (SPRO) SPERO THERAPEUTICS Posts Q1 Revenue $2.1M, vs. Street Est of $1.93M